CF
TTOO

Copperwynd Financial’s T2 Biosystems, Inc TTOO Stock Holding History

Copperwynd Financial’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$2.21K – 144
2023
Q3 		$2.21K Buy
+100
New +$2.61K ﹤0.01% 128

Other funds holding TTOO

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Copperwynd Financial's TTOO Position: Q4 2023 in Review

Copperwynd Financial sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 100 shares — an estimated $2.21K sold.

Copperwynd Financial first reported a position in TTOO in Q3 2023 and held it in 1 quarter. The position peaked at $2.21K in Q3 2023. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

  • Copperwynd Financial reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
  • Copperwynd Financial sold 100 T2 Biosystems, Inc shares in Q4 2023, an estimated $2.21K.
  • Copperwynd Financial first reported a position in T2 Biosystems, Inc in Q3 2023 and held it in 1 quarter.
  • Copperwynd Financial's T2 Biosystems, Inc position peaked at $2.21K in Q3 2023.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Copperwynd Financial's 13F filing for Q4 2023, filed 13 Feb 2024.